Aristotle University Of Thessaloniki (AUTH)
Διαγνωστική και προγνωστική αξία της μέτρησης της ενεργότητας των αιμοπεταλίων στην έκβαση του οξέος ισχαιμικού αγγειακού εγκεφαλικού επεισοδίου και στην αποτελεσματικότητα της αντιθρομβωτικής αγωγής
Abstract
dc:descriptionIntroduction: Stroke remains one of the leading causes of morbidity and mortality worldwide. Its pathogenesis involves disturbances in vascular integrity and hemodynamic balance, along with inflammatory and procoagulant mechanisms that promote thrombogenesis. The aim of this study was to evaluate novel biomarkers of platelet and endothelial activation and to explore their diagnostic and prognostic significance in stroke outcome. Methods: This study included 100 patients with acute ischemic or transient ischemic attack and 30 controls. Demographic, clinical, and laboratory data were collected for all participants, while stroke severity and functional outcome were assessed using the NIHSS and mRS scales, respectively. Plasma levels of von Willebrand Factor (vWF), Tissue Factor (TF), soluble P-selectin (sP-selectin), soluble CD40 Ligand (sCD40L), Thromboxane B₂ (TXB₂), and Monocyte Chemoattractant Protein-1 (MCP-1) were measured using ELISA. Patients were followed up for 12 months to evaluate functional outcome and mortality. Statistical analysis included univariate and multivariate models as well as ROC curve analysis to assess diagnostic performance. Results: Patients with stroke showed significantly higher levels of vWF (p<0.001), TF (p<0.001), MCP-1 (p<0.001), and TXB₂ (p<0.001) compared to controls, whereas sP-selectin and sCD40L did not differ. ROC analysis revealed high diagnostic accuracy for vWF (AUC=0.946, cut-off=1965.5 mIU/mL, Se=90.0%, Sp=86.7%), as well as for TF (AUC=0.900), MCP-1 (AUC=0.899), and TXB₂ (AUC=0.842). No significant differences were observed between ischemic stroke and transient ischemic attack or among ischemic stroke subtypes according to TOAST classification. VWF correlated positively with stroke severity at admission (NIHSS, B=0.003, p=0.028), whereas MCP-1 was independently associated with poorer functional outcome at 12 months (mRS, B=0.003, p=0.007) and showed a borderline association with 12-month mortality (p=0.052). Conclusions: This study demonstrated a significant increase in vWF, TF, MCP-1, and TXB₂ levels during the acute phase of stroke, highlighting their diagnostic potential and reflecting the interaction between platelet activation, endothelial dysfunction, and inflammatory response. VWF was associated with stroke severity, while MCP-1 correlated with unfavorable long-term outcome and increased mortality. In contrast, sP-selectin and sCD40L showed no diagnostic or prognostic value in the acute phase. Overall, these findings suggest that novel biomarkers may serve as promising complementary tools for the diagnosis and prognostic evaluation of stroke.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Ztriva, Eleftheria
- Ζτρίβα, Ελευθερία
Subjects
dc:subject × 22- Αγγειακό εγκεφαλικό επεισόδιο
- Βιοδείκτες
- Ενεργοποίηση αιμοπεταλίων
- Ενδοθηλιακή δυσλειτουργία
- Stroke
- Biomarkers
- Platelet activation
- Endothelial dysfunction
- Von Willebrand Factor (vWF)
- Tissue Factor (TF)
- Monocyte Chemoattractant Protein-1 (MCP-1)
- Thromboxane B₂ (TXB₂)
- Soluble P-selectin (sP-selectin)
- Soluble CD40 LIGAND (SCD40L)
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Κλινική ιατρική, άλλοι τομείς
- Αιματολογία
- Clinical Medicine
- Medical and Health Sciences
- Clinical medicine, miscellaneous
- Hematology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60054